Gain Therapeutics, Inc. (GANX): Capital Expenditures
$22.5K
Year ended 2024-12-31
-38.0%
3-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $22.5K | +46.5% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $15.4K | -87.1% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $119.0K | +26.3% | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | $94.2K | +352.4% | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | $20.8K | n/a | 2022-03-25, From 2020-01-01 |